Search Results 1271-1280 of 18751 for Relapse
This phase II trial is studying the side effects and how well cixutumumab works in treating patients with relapsed or refractory solid tumors. Monoclonal ...
The purpose of this study is to determine the safety and best dose of PRGN-3006 T Cells to treat relapsed/refractory Acute Myeloid Leukemia and High Risk ...
Patients who have developed an asymptomatic relapse as defined by: Cohort A: CA-125 ≥ 2 times ULN on 2 occasions at least 1 week apart (GCIG criteria) or ...
... relapse in osteosarcoma patients in complete surgical remission following one or two prior pulmonary relapses. Cardiotoxic Effects of Chemotherapy in ...
NL-201 in Patients With Relapsed or Refractory Cancer. Rochester, Minn., Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The purpose of this study is to ...
Also, to improve disease control by decreasing the number of spinal relapses ... Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients with ...
Root Cause of Multiple Myeloma Relapse Revealed. Dana Sparks. September 18, 2013. Mayo Clinic Receives $8.8 Million Federal Grant for Metabolomics Center.
Treatment-naïve or relapsed/refractory CLL patients undergoing CLL antineoplastic treatment. Diagnosis of B-cell CLL established according to International ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.